Terms: = Bone cancer AND PTK6, BRK, 5753, ENSG00000101213, Q13882, FLJ42088
2 results:
1. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and ptk6-mediated cell survival.
Yu G; Lee YC; Cheng CJ; Wu CF; Song JH; Gallick GE; Yu-Lee LY; Kuang J; Lin SH
Mol Cancer Res; 2015 Feb; 13(2):348-57. PubMed ID: 25189355
[TBL] [Abstract] [Full Text] [Related]
2. Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).
Uckun FM; Dibirdik I; Qazi S; Vassilev A; Ma H; Mao C; Benyumov A; Emami KH
Bioorg Med Chem; 2007 Jan; 15(2):800-14. PubMed ID: 17098432
[TBL] [Abstract] [Full Text] [Related]
